Skip to content

Effect analysis and mechanism study of modified translabyrinthoacoustic nueroma reserction with cochlear nerve and cochlear nerve and cochlear structure preserved

Effect analysis and mechanism study of modified translabyrinthoacoustic nueroma reserction with cochlear nerve and cochlear nerve and cochlear structure preserved

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069305
Enrollment
Unknown
Registered
2023-03-13
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acoustic neuroma

Interventions

experimental group (A modified labyrinthian operation was performed):None
control group (Traditional labyrinth approach was performed):None

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Intracranial MRI examination confirmed internal auditory canal occupation; 2. Unilateral internal auditory tract occupying/acoustic neuroma; 3. Aged 15-70 years; 4. Patients without functional hearing had PTA > 50 dB nHL, speech recognition rate 2.5cm.

Exclusion criteria

Exclusion criteria: 1. Refuse to participate in the program or fail to complete follow-up; 2. Patients with neurofibromatosis II (NF2), namely bilateral acoustic neuroma; 3. Had undergone surgery or radiotherapy; 4. Previous craniocerebral operations; 5. Non-acoustic neuroma patients with intraoperative or postoperative pathological diagnosis.

Design outcomes

Primary

MeasureTime frame
Assessment of related neurological function: facial paralysis, tinnitus, vertigo, hearing;Tumor excision, residual and recurrence;Evaluation of cochlear structure;Evaluation of cochlear nerve structure and function;

Secondary

MeasureTime frame
Postoperative headache;

Countries

China

Contacts

Public ContactHan Dongyi

Chinese PLA General Hospital

hdy301@263.net+86 13701102913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026